
HBS Reporting
Fauci says vast majority of vaccinated Americans should get a COVID-19 booster
-
HBS Reporting
Moscow city orders compulsory COVID-19 shots for 2 million workers
Jun 17, 2021MOSCOW, June 16 (Reuters) – Moscow city authorities ordered all workers with public facing roles to...
-
HBS Reporting
Novartis prostate cancer drug receives U.S. FDA breakthrough designation
Jun 17, 2021ZURICH, June 16 (Reuters) – Swiss drugmaker Novartis AG (NOVN.S) has received breakthrough therapy designation from...
-
HBS Reporting
UK’s Johnson set to announce delay to end of COVID restrictions
Jun 15, 2021British Prime Minister Boris Johnson is expected to announce on Monday that the end of COVID-19...
-
HBS Reporting
Rapid spread of Delta variant throws England’s re-opening into doubt
Jun 15, 2021LONDON (Reuters) – British Prime Minister Boris Johnson’s hopes of ending England’s coronavirus lockdown on June...
-
HBS Reporting
China reports 16 new coronavirus cases on June 8
Jun 9, 2021China reported 16 new coronavirus cases on the mainland for June 8, down from 33 cases...
-
HBS Reporting
U.S. CDC eases travel recommendations on some 110 countries, territories including Japan
Jun 9, 2021The U.S. Centers for Disease Control and Prevention (CDC) has eased travel recommendations for more than...
-
HBS Reporting
Pfizer to test COVID-19 vaccine in larger group of children below 12
Jun 9, 2021(Reuters) – Pfizer Inc said on Tuesday it will begin testing its COVID-19 vaccine in a...
-
HBS Reporting
Australia’s Melbourne looks set to lift COVID-19 lockdown after low cases
Jun 9, 2021Australia’s Victoria state reported its lowest rise in new locally acquired COVID-19 cases in more than...
-
HBS Reporting
Biden Asia chief ‘relatively confident’ on billion vaccine timing despite India crisis
Jun 9, 2021President Joe Biden’s Indo-Pacific policy chief said on Tuesday he was “relatively confident” a target for...
-
HBS Reporting
Runner with Alzheimer’s hopes new drug will keep him on track
Jun 9, 2021For Bill McKay, 69, of Haslett, Michigan, the U.S. approval of Biogen Inc’s (BIIB.O) controversial Alzheimer’s...